Krummnow, A.;                     Danzer, A.;                     Voges, K.;                     Dohrn, S.;                     Kyeremateng, S.O.;                     Degenhardt, M.;                     Sadowski, G.    
        Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics 2022, 14, 1904.
    https://doi.org/10.3390/pharmaceutics14091904
    AMA Style
    
                                Krummnow A,                                 Danzer A,                                 Voges K,                                 Dohrn S,                                 Kyeremateng SO,                                 Degenhardt M,                                 Sadowski G.        
                Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics. 2022; 14(9):1904.
        https://doi.org/10.3390/pharmaceutics14091904
    
    Chicago/Turabian Style
    
                                Krummnow, Adrian,                                 Andreas Danzer,                                 Kristin Voges,                                 Stefanie Dohrn,                                 Samuel O. Kyeremateng,                                 Matthias Degenhardt,                                 and Gabriele Sadowski.        
                2022. "Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions" Pharmaceutics 14, no. 9: 1904.
        https://doi.org/10.3390/pharmaceutics14091904
    
    APA Style
    
                                Krummnow, A.,                                 Danzer, A.,                                 Voges, K.,                                 Dohrn, S.,                                 Kyeremateng, S. O.,                                 Degenhardt, M.,                                 & Sadowski, G.        
        
        (2022). Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics, 14(9), 1904.
        https://doi.org/10.3390/pharmaceutics14091904